cervarix

Walking on the Edge of a Sword: Cervarix Injury in Japan

Published on
3529 views
cervarix

This is the story of my teenage daughter who, beginning in 2010, received a series of vaccinations that culminated with the three shot HPV vaccine, Cervarix (Gardasil in the US). Although she had some health issues as an infant and child, she was thriving and doing well prior to the vaccine. After the Cervarix vaccine series this all changed.

Sharne was born in 1998. Her health issues pre-vaccine included: pervasive developmental disorder (PDD), a form of Aspergers, infantile asthma, atopic dermatitis, pyelitis, otitis media, Candida, hemolytic streptococcus, pneumonia, wart, FMF (periodic fever syndrome), agrochemical sensitivity and repeated stomatitis. Her immunization history was as follows:

  • 15 May 2010 DT BIKEN (Lot. No. 2E007 2011.6.8, 0.1ml) left arm
  • 19 March 2011 Japanese encephalitis BIKEN (JR059 2012.5.18, 0.5ml) left arm
  • 25 June 2011 Measles and Rubella Takeda (Lot. No. Y116 2012.2.24, 0.5ml) left arm
  • 27 July 2011 HPV  Cervarix  1st shot (Lot. No. AHPVA129CA, 0.5ml) left arm
  • 17 October 2011  Cervarix  2nd shot (Lot. No. AHPVA143AA, 0.5ml) right arm
  • 26 March 2012  Cervarix  3rd shot (Lot. No. AHPVA161BA 0.5ml) left arm

Before the Cervarix Vaccine

Sharne was born October 02, 1998. Prior to Cervarix vaccine, she enjoyed her school life. She liked to be in the school rather than being home, including going to an evening school for extra study.  As she wanted to gain accreditation to a high school, she tried to go to school even when she had a fever of 40 degree centigrade because in order to get the accreditation she was allowed to be absent from school only up to 5 days

Prior to the HPV vaccine, Sharne did not need to sleep for a long time, and she woke up early even when she went to bed late the day before. Before the symptoms occurred, she used to wake up at five o’clock in the morning. She’d read her favorite books, and then went to run around the house for about 10 minutes.

She was an athlete and was the fastest 1000 meter runner in her class when she was in 7th grade. She had strong lungs, and her respiration rate and pulse rate had been low since she was a little girl, but it is now is much higher. Her pulse is averages 70-80 beats per minute; average for some, but several points higher for her.

She used to prepare breakfast by herself, do homework and go to school. She was really independent, managed her own schedule, found whatever she wanted to do, and when she needed to be taken to or picked up she just told me the time to be taken to or picked up.  She never conflicted with others, avoided any dispute, and was a very quiet, gentle and good natured child.

After the Cervarix Vaccine

Now she cannot do what she could do previously. She has difficulties remembering things. She cannot remember what she has done. She cannot manage her own things, stationary, notebooks, glasses.  She used to look after her things very carefully, and never asked where they were. She’d never forgotten what she needed to take to school, but now she leaves her glasses on the floor of her bedroom or in a washing bowl even for two weeks. She cries when she cannot find her notebook, and she cannot remember what she did in the past.

Her IQ and test scores have dropped a lot and continue to drop.

She says impolite things to teachers or family members and becomes violent like an insane person. She hates most of people around her.

Recently, she cannot understand what she is going to do or where she is. In addition, she has muscle weakness in legs, and cannot raise her left foot. Her grip strength dropped from about 30 kgf to 5 or 6 kgf.

The Progression of Symptoms Post – HPV Vaccine

Looking back now, it seemed to have started after the first Cervarix shot, but it gradually worsened for about two weeks after the third shot, and half a year later she could not get up at all. Symptoms:

  • After 1st shot: asthma attack (the first time for seven years).
  • After 2nd shot: malaise, long-lasting urticaria, repeated nosebleed
  • After 3rd shot: in MRI, extension of T2, cerebral blood flow decrease, atrial rhythm, arrhythmia, increase of eosinophil, IgE, IgD, and complement titer, abnormal malaise, chronic slight fever, clouding of consciousness, hypersomnia, brain function deterioration such as memory, comprehension, calculation, and execution functions, personality change, irritability, aggression, depression, childishness, behaving like a baby, hyperpnea, respiratory distress, muscle weakness, back pain, headache, parotitis, temporomandibular arthritis, dysphagia, stomatitis, abdominal pain, vomiting, diarrhea, back pain, muscle pain, abnormal vision, photophobia, double vision, reduced vision, etc.

Timeline of Symptoms Post Cervarix Shots

2012

April: about 2 weeks after the third shot (March 26), exertional hyperpnoea and muscle weakness occurred.

May or June: started experiencing malaise, gastrointestinal symptoms such as vomiting, headache, chest pain, and anginal symptoms during nocturnal rest. There was muscle weakness when getting off from her bicycle in the school and could not stand up.

September: could not get up, altered state of consciousness lasted for a long time, there were anginal symptoms, atrial rhythm, arrhythmia, blood flow decrease, extension of T2 in MRI, and leukoaraiosis.

October to December: treated with steroid. Although malaise had dramatically improved, brain blood flow did not improve, accumulation was observed in the hippocampus, and the treatment was stopped.

 2013

January: malaise worsened seriously. There were depression, suicidal thought, and personality change (irritability, excitability, persecutory delusion).  Even in school she cried loudly like a one-year old baby and dashed out from the classroom.

June: we noticed the association with the vaccine when watching a TV news about suspension of recommendation of HPV vaccine.  Around this time, she became violent at night. Cried loudly like roaring. Sharne threw her younger brother by the full force. (This violence disappeared soon after IVIG.)

August: we saw Dr. Sasaki, and he proposed three treatments, that included, steroid pulse, IVIG, and an immunosuppressive agent.

September: immunoglobulin (due to fever, discontinued on the 3rd day, she became cheerful on the 2nd day, and the sensation of toes returned. Malaise also improved a little.  Blood flow increased, and the best results for SPECT so far), but involuntary movement gradually intensified.

2014

February: steroid pulse (after about 2 weeks, headache and back ache, etc. decreased, cognitive function and facial expression a improved slightly, the time of sleep during day decreased, but after about 20 days new systemic joint pain and excruciating pain started, and malaise, gastrointestinal symptoms, etc. also restarted.)

Her sensitivity to glare and the double vision disappeared.  Involuntary movement started to appear.

March: 2nd cycle of steroid pulse (this time, there were no effects on mental strength and malaise, and there was a symptom like muscle weakness, which had appeared with the altered state of consciousness in the autumn 2012), involuntary movement and muscle weakness seemed to increase, and IgG decreased.

May: she was depressed. She received immunoadsorption therapy, involuntary movement decreased, but spasm and tremor have started. Mental motivation improved, and gentle character has returned. Malaise has alleviated, and daily life became almost normal.

June: malaise returned in one week after discharge from the hospital, and IgG decreased.

July: motivation dropped. Mental symptoms have started.

Lab Tests and Other Diagnostic Results

  • Cerebrospinal fluid test results: autumn 2013: contaminated with blood, but IgG was as high as 5.8 (this is not influenced by serum contamination)
  • February 2014: cell count 12, CD4 64.9, CD8 31.4, cytotoxic T cell, granzyme B 1.3
  • Diagnosed as a possibility of subacute encephalitis.
  • April 2014: abnormal values for various types of interleukins, etc.
  • June 2014: antiganglioside antibody positive

The Lesson I Learned too late

‘We need question even what the government is doing.’ This is what I learned with this huge and irreparable mistake. I tell our story because I do not want to other parents to make the same mistake and because we need help understanding the post-vaccine reactions, so that our children, already injured by the Cervarix vaccine can recover.

Vaccination of boys has already started in some countries, and clinical trials have begun in Japan. In order to protect the future of children, please think and research before you vaccinate. I will let my voice be heard in order for many people to receive information about the dangers of the HPV vaccine.

Cervarix Adverse Effects in Japan

There are more than 2000 reports about adverse effects in Japan, but some doctors refuse to report. There have been more than 1000 contacts to the network of HPVW injured people in Japan, the number of people registered exceeds 255, but still there are only a few medical institutions that care for injured.  The government should support and subsidize medical institutions that exert themselves for elucidation of the mechanisms of the cause and establishment of the way to treat underlying causes.

Postscript: This article was written originally in Japanese and translated to English by a friend of Hormones Matter.

Participate in Research

Hormones MatterTM is conducting research on the side effects and adverse events associated with Gardasil and its counterpart Cervarix. If you or your daughter has had either HPV vaccine, please take this important survey. The Gardasil Cervarix HPV Vaccine Survey.

Hormones MatterTM conducts other crowdsourced surveys on medication reactions. To take one of our other surveys, click here.

To sign up for our newsletter and receive weekly updates on the latest research news, click here.

What Else Can I Do To Help?

Hormones MatterTM is completely unfunded at this juncture and we rely entirely on crowdsourcing and volunteers to conduct the research and produce quality health education materials for the public. If you’d like help us improve healthcare with better data, get involved. Become an advocate, spread the word about our site, our research and our mission. Suggest a study. Share a study. Join our team. Write for us. Partner with us. Help us grow. For more information contact us at: info@hormonesmatter.com.

To support Hormones Matter and our research projects – Crowdfund Us.

Related posts:

low aldosteroneFrom Frozen Shoulder to Barely Walking and Low Aldosterone

You might be interested in

HPV Vaccines are not Effective, Safe or Necessary

Published on
4647 views
Judy Wilymen

I was recently invited to present my research on the HPV vaccine at the Euroscicon Controlling Cancer Summit held in London on 12 May 2014. The theme of the presentations was Advances in Cancer Screening and Prevention Research and the paper I presented was titled: HPV vaccines have not been demonstrated to be safe and effective in the prevention of cervical cancer.

HPV Infections Mostly Harmless

In my presentation I provided evidence that HPV infections are harmless and asymptomatic unless specific environmental co-factors are also present. This is why HPV infections should not be feared by the public and why the medical literature states that cancer is a rare outcome from any type of HPV infection. The fact that cervical cancer is a higher risk in developing countries than in developed countries is explained by the presence of environmental co-factors that are necessary for an HPV infection to progress to cancer. These co-factors (risk factors) are more prevalent in the developing countries. The fact that HPV infections are mostly harmless on their own means that vaccinating all women in developed countries (e.g. Australia, US and the UK) results in the majority of women (99%) being on a drug for a disease that they are not at risk of getting. This is not cost-effective and it is also not necessary because the vaccine has not been proven to be safer or more effective than Pap screening combined with surgery.

If the HPV vaccines are proven to have value in years to come it could be offered to women in the high-risk category. That is, women who are exposed to the environmental co-factors that are necessary for an HPV infection to progress to cervical cancer. However, as yet the vaccine has not been proven to be safe or effective in preventing cervical cancer. Currently governments are claiming that because the HPV vaccine targets 2 of the 15+ strains of HPV associated with causing most cervical cancer, it will prevent some cervical cancer, but they have not determined how much can be prevented. This argument is flawed if the majority of women on the drug are not at risk of cervical cancer and if there is already an effective method of preventing cervical cancer in place. In this case, Pap screening combined with surgery is an effective method of prevention (9 out of 10 cancers) and it is risk free and will still be required by vaccinated women.

The Global Harm Associated with HPV Vaccines

Currently there is much global debate about the harm that is being associated with HPV vaccination programs. As of June 2014 Japan has stopped recommending this vaccine until further safety studies have been conducted. India and Utah have also stopped recommending this vaccine and France is considering similar action. In France the use of HPV vaccine was debated in an open scientific forum on 22 May 2014. This forum allowed all stakeholders to present their case to the French parliament. This is the debate that governments and health professionals are not having in many other countries, for example, Australia.  In fact, the Australian government is recommending this vaccine free to all adolescent girls and boys in school programs without a debate about its safety and efficacy in preventing cervical cancer (a non-infectious disease).

HPV Vaccine Adjuvants

The HPV vaccine has two ingredients that are linked to causing infertility. These are sodium borate and polysorbate 80 and the Australian government has not explained why these ingredients are in a vaccine that is being recommended free to adolescents. This vaccine also has three times as much aluminium hydroxyphosphate sulphate (an adjuvant that is linked to autoimmune diseases and hypersensitivity) as any other vaccine and three times as many adverse events have been reported to this vaccine. The most common adverse events are neurological conditions and autoimmune diseases.

Adverse Events Associated with HPV Vaccines

Since the introduction of HPV vaccines 34,700 adverse events have been voluntarily reported to the US CDC, including 157 deaths and 6,977 permanent disabilities and chronic illness. This is possible because the Merck (vaccine manufacturer) funded Phase 3 clinical trials for Gardasil vaccine did not use an ‘inert’ (non-active) placebo in the unvaccinated control group. They used aluminium adjuvant in the comparison group and they did not collect long-term adverse events. The clinical trials only followed the health outcomes of all vaccinated girls actively for 15 days after vaccination. After this time the reporting of AE’s was voluntary which does not allow scientists to make causal relationships to the vaccine.

Here is a link to a video of the serious adverse events that some girls have experienced after using this vaccine. These have included seizures, paralysis, convulsions, tics, encephalopathy, chronic fatigue syndrome and death. The parents of injured children and those that have died after vaccination urge you to research this vaccine before you trust the government’s recommendation of this vaccine.

Report from the French Parliament on the Safety of Aluminium Adjuvant in HPV Vaccines (22 May 2014) 

The public hearing held in Paris on the safety of aluminium adjuvants in vaccines was attended by the French Health Minister and reported on by the European parliament. The hearing was open to the press and titled ‘Vaccine Adjuvants: A Controversial Question’. The most recent science on aluminium adjuvants in vaccines demonstrates that many individuals have a pre-disposition (genetic condition) to experiencing a serious reaction from aluminium adjuvants in vaccines. These serious reactions include neurological damage and autoimmune diseases – multiple sclerosis, arthritis, lupus, etc – and are caused by the artificial stimulation of the immune system with vaccines. Here is a link to the report on the public hearing http://sanevax.org/french-vaccine-debates-immediate-measures-required/

This indicates the significance of fully informing parents about the vaccines that are recommended in government vaccination programs and the importance of vaccines being administered by general practitioners with an assessment of the family history of the patient. Vaccines are a medical intervention and they should not be administered in school programs because family history is a contraindication to vaccination.

Conclusion

Cervical cancer is curable with early detection by Pap screening (9 out of 10 cancers) and all vaccinated women will still need Pap screening. This is because the vaccine (costing $Au450 per person) does not target ~30% of cervical cancer (13+ strains of high-risk HPV are not covered in the vaccine) – even if it is proven to be of some value in years to come. It is also a fact that HPV infections are harmless unless specific environmental co-factors are also present and this is why vaccinating all women in developed countries results in the majority of women (99%) being on a drug for a disease they are not at risk of getting.

Reference

Wilyman J, 2013, HPV vaccination programs have not been shown to be cost-effective in countries with comprehensive Pap screening and surgery. Infectious Agents and Cancer. 8:21 (June): pp1-8.

About the Author: Judy Wilyman MSc, is a PhD Candidate studying Population Health Policy at the University of Wollongong (UOW) School of Social Sciences, Wollongong, Australia. She is the founder of Vaccination Decisions, a website that she has set up to present her research.

Participate in Research

Hormones MatterTM is conducting research on the side effects and adverse events associated with Gardasil and its counterpart Cervarix. If you or your daughter has had either HPV vaccine, please take this important survey. The Gardasil Cervarix HPV Vaccine Survey. 

To take one of our other Real Women. Real Data.TM surveys, click here.

To sign up for our newsletter and receive weekly updates on the latest research news, click here.

What Else Can I Do To Help?

Hormones MatterTM is completely unfunded at this juncture and we rely entirely on crowdsourcing and volunteers to conduct the research and produce quality health education materials for the public. If you’d like help us improve healthcare with better data, get involved. Become an advocate, spread the word about our site, our research and our mission. Suggest a study. Share a study. Join our team. Write for us. Partner with us. Help us grow. For more information contact us at: info@hormonesmatter.com.

To support Hormones Matter and our research projects – Crowdfund Us.

Related posts:

No related posts.

You might be interested in

The Pharma Funded Promotion of HPV Vaccines

Published on
3978 views
July Wilymen

Promotional campaigns for HPV vaccines have informed women that infections from HPV-16 and -18 are the cause of most cervical cancer. However, in 2006/7 when HPV vaccination programs were implemented globally, the scientific community knew that most women do not develop cervical cancer or warts after any type of HPV infection – including HPV-16/-18. HPV infections from all sub-types are found in high frequency among women with normal cervices and cervical cancer is a rare outcome from these infections. This demonstrates that HPV infection of any sub-type (including HPV-16 and -18) is not predictive of cancer; particularly as ninety percent of HPV infections have no clinical consequences at all. It has been known for decades that environmental and lifestyle co-factors are also necessary for HPV infections to progress to cervical cancer. This is why 83% of cervical cancer occurs in the developing countries.

Does the HPV Vaccine Prevent Cervical Cancer?

The promotional campaigns for HPV vaccines have been designed and funded by the pharmaceutical companies. This vaccine has not been demonstrated to prevent cervical cancer. It was trialled against a surrogate for cervical cancer – pre-cursor lesions (grade 2/3) in 15-26 year old women – and these lesions are not predictive of cancer later in life. More than 95% of high-grade lesions (CIN 3) in young women (15-26 years) regress without treatment. In addition, the phase 3 clinical trials that tested the vaccine against pre-cursor lesions were conducted from 2003 to 2007 and were not complete when the HPV vaccine was licensed by the US Food and Drug Administration in June 2006. The vaccine was fast tracked for approval by the FDA due to industry lobbying and Merck ensured that Gardasil® was not just approved for high-risk groups. The FDA approved the vaccine for universal use in all women even though it was known that many co-factors, that were not prevalent in developed countries (Australia, USA and UK), were essential for HPV infections to progress to cervical cancer. The time frame from application to approval of the HPV vaccine by the FDA was only 6 months and 3 weeks later the CDC recommended the vaccine for use in all women.

Yet the phase 3 clinical trials to determine the safety and efficacy of this vaccine against cervical cancer were not completed until 2007. In the US, the 1986 National Childhood Vaccine Injury Act removes liability from vaccine manufacturers for all design faults and negligence relating to their vaccines [1]. The US government has a no-fault compensation program that is tax-payer funded. This program removes all liability from the vaccine manufacturers and there is no onus to demonstrate that their products are safe and effective before they are implemented in the population. However, only Americans can seek compensation from the US government program. People who are harmed by HPV vaccines in other countries, such as Australia, receive no compensation from their governments.

Lobbying for HPV Vaccine Approval

Merck & Co is the manufacturer of the Gardasil® vaccine and when the medical director, Dr. Richard Haupt, was questioned about the speed with which the HPV vaccine was brought to the market he replied ‘Our hope and belief is that this is a remarkable vaccine that will have a huge impact on women’ [2]. ‘Hope’ and ‘belief’ are not the same as scientific evidence.

Politicians were lobbied and invited to receptions urging them to legislate against a ‘global killer’ [2]. Abramson, the chairman of the committee of the CDC that recommended the vaccine for all girls aged 11 or 12, stated ‘there was incredible pressure from industry and politics’ to approve this vaccine [2]. Diane Harper, a scientist involved in the development of the vaccine, agreed ‘Merck lobbied every opinion leader, women’s group, medical society, politicians and went directly to the people – it created a sense of panic that says you have to have this vaccine now’ [2]. In the US pharmaceutical companies are allowed to advertise directly to the public and the campaigns for HPV vaccines were very aggressive.

Educating Physicians about the HPV Vaccine

It was important for Merck to promote the vaccine through trusted sources and this was done by securing government reimbursement and mandates to promote the vaccine to all women, not just high-risk populations [3]. This enabled Merck to fund the professional medical associations (PMA’s) to promote the vaccine. The pharmaceutical companies supplied the medical associations with a Speaker Lecture Kit. This included ready-made presentations and letters to promote Gardasil® as a preventative for cervical cancer, even though the data was incomplete. The commercials for Gardasil® stated in small print ‘the duration of protection has not been established’ [2]. Much of the promotional material did not address the complexity of the issues surrounding the vaccine and did not provide balanced advice regarding the risks and benefits of the vaccine [3]. It was also presented in a way that obscured the involvement of pharmaceutical companies.

Doctors and nurses were recruited for an ‘Educate the Educators’ program created by the pharmaceutical companies to train health professionals to promote the vaccine. The PMA’s maintained a registry of educators and participants lectured to thousands of healthcare professionals. Hundreds of doctors were paid $4,500 per 50 minute lecture to present the information supplied by the pharmaceutical companies at Merck sponsored conferences [3]. They were also paid to attend advisory board meetings to discuss the vaccine [2]. In addition, there has also been an increase in cervical cancer awareness for patient groups financed with the help of Merck and GlaxosmithKline: often the financial support is indirect so patients are unaware that ‘expert’ advice has been paid for by the vaccine makers [2].

One of the Speaker Kit medical slides stated ‘Cervical cancer screening is described as secondary prevention identifying a precursor lesion; the HPV vaccine is primary prevention that would eliminate the cause of cervical cancer’ (Speaker Lecture Kit slide 13 in Rothman and Rothman 2009). This information is dishonest because it does not inform women that HPV alone is not sufficient to cause cervical cancer and also that there are 13+ other cancer causing strains of HPV that are not covered by the vaccine. Hence, the vaccine will not eliminate the cause of cervical cancer.

Whilst the slides acknowledged the uneven distribution of cervical cancer rates globally they did not draw attention to the risk factors that make cervical cancer a higher risk for women in developing countries. This knowledge is critical to women in determining the necessity for using this vaccine. The education campaigns emphasized the worldwide incidence of this disease whilst leaving out the risk factors for the disease and precautions about the risks of vaccines. Merck also funded the American College Health Association (ACHA) Vaccine Toolkit for clinicians [3]. This included talking points, sample e-mail messages to students and parents and sample press releases and public service announcements. At no time has the public been informed that the information they received on this vaccine was designed by pharmaceutical companies.

Protecting Population Health

The pharmaceutically funded promotional campaigns for HPV vaccines have maximized the threat of HPV infections and minimised the environmental and lifestyle co-factors that are necessary for the development of cervical cancer. The public places its trust in medical associations to provide non-biased science to health professionals for the promotion of medical products to the community. Clearly this trust has been breached in the case of HPV vaccines. At a minimum the public is entitled to be informed openly about relationships with industry and precise funding arrangements in order that they can weigh up the credibility of the information. This was an intentional deception as the pharmaceutical companies sought to present their information through trusted sources and the PMA’s condoned it.

Population health cannot be protected if there is no accountability for the health information that is supplied to doctors from industry funded research and presented to the community in the mainstream media.

About the author: Judy Wilyman MSc (Population Health), PhD Candidate University of Wollongong. More facts about HPV infections and the development of cervical cancer have been published in the Infectious Agents and Cancer Journal and can be accessed here:  HPV vaccination programs have not been shown to be cost-effective in countries with comprehensive Pap screening and surgery.

References

  1. Habakus LK and Holland M (Ed), 2011, Vaccine Epidemic: how corporate greed, biased science and coercive government threaten our human rights, our health and our children. Center for Personal Rights.
  2. Rosenthal E, 2008, The Evidence Gap: Drug Makers Push Leads to Cancer Rise, The New York Times, August 20, accessed 21.12.09
  3. Rothman SM and Rothman DJ, 2009, Marketing HPV Vaccine: Implications for Adolescent Health and Medical Professionalism, Journal of the American Medical Association, Vol 302, (7) p. 781 – 785.

Participate in HPV Vaccine Research

Hormones MatterTM is conducting research on the side effects and adverse events associated with Gardasil and its counterpart Cervarix. If you or your daughter has had either HPV vaccine, please take this important survey. The Gardasil Cervarix HPV Vaccine Survey.

Hormones MatterTM conducts other crowdsourced surveys on medication reactions. To take one of our other surveys, click here.

To sign up for our newsletter and receive weekly updates on the latest research news, click here.

What Else Can I Do To Help?

Hormones MatterTM is completely unfunded at this juncture and we rely entirely on crowdsourcing and volunteers to conduct the research and produce quality health education materials for the public. If you’d like help us improve healthcare with better data, get involved. Become an advocate, spread the word about our site, our research and our mission. Suggest a study. Share a study. Join our team. Write for us. Partner with us. Help us grow. For more information contact us at: info@hormonesmatter.com.

To support Hormones Matter and our research projects – Crowdfund Us.

 

Related posts:

No related posts.

You might be interested in

Cerebellar Ataxia and the HPV Vaccine – Connection and Treatment

Published on
6247 views

Anecdotal evidence points to a connection between Gardasil and Cervarix, the HPV vaccines, and cerebellar injury. Here, from the journal Neuropediatrics comes the first published report linking the HPV vaccine to cerebellar ataxia: Association of Acute Cerebellar Ataxia and Human Papilloma Virus Vaccine: A Case Study.

I should note, from our research we’re also seeing cases of cerebellar ataxia post fluoroquinolone reaction and related to Hashimoto’s thyroiditis. The cerebellum appears to be particularly sensitive to insult from environmental toxins – to functional mitochondrial injuries, perhaps because it collects the millions of peripheral nerves coming from the body that control sensation and movement, as they pass to higher brain centers. As such, the cerebellum demands high levels of oxygen and nutrients.

For those of our readers new to neuroanatomy, the cerebellum is the cauliflower looking section at the base of the brain that controls motor coordination – the ability to perform coordinated tasks such as walking, focusing on a visual stimuli and reaching for objects in space. The walking and balance disturbances associated with cerebellar damage or degeneration have a very distinct look, a wide gait, with an inability to walk heal to toe – very much like a drunken sailor. Videos of cerebellar ataxia can be seen here.

The Case Details: Acute Cerebellar Ataxia Post HPV Vaccine

Approximately, two weeks after receiving the HPV vacccine, Cervarix, a previously healthy 12.5 year old girl developed nausea and dizziness with severe cerebellar ataxia, tremors and nystagmus. Initial tests came back normal and she was hospitalized on day 20 post HPV vaccine. Though she could sit on her own, she could not stand or walk unaided and the nystagmus prevented her from focusing on TV, reading or other activities. She had no fever. Heel-knee-shin and finger-nose tests indicated ataxia with terminal intention tremor and dysmetria (see videos: horizontal nystagmus or here for multiple types of nystagmus, heel-knee-shin test, finger-nose test).

All blood tests, cerebral spinal fluid tests and imaging tests were normal, with the exception of testing positive for IgG and varicella zoster virus – chicken pox and shingles – indicating earlier exposure. Tumors, paraneoplastic disease, cardiovascular disease, metabolic conditions and labyrinthitis (inner ear disturbance) were all ruled out. Her symptoms did not remit as was expected with acute cerebellar ataxia.

Treatment Options for Acute Cerebellar Ataxia

Beginning on day 25 post HPV vaccine, pulsed IV methylprednisone (1000mg/d) was administered for three days. Her symptoms persisted. On day 44 post HPV vaccine, IV immunoglobulin (IVIG) at 400mg/kg was initiated and run for 5 days. Her symptoms persisted.

At day 65 post vaccine, with no indication of improvement, immunoadsorption plasmapharesis was begun at a rate of seven times per month. The physicians report a gradual improvement of the nystagmus after two treatments with a full resolution of symptoms after 19 courses of treatment (day 134 post HPV vaccine). The improvement was short-lived, however, and beginning at day 220 post HPV vaccine, the symptoms began to return, gradually at first with nystagmus, and then completely. Immunoadsorption plasmapharesis was begun anew on day 332 post HPV vaccine. After five courses of treatment, the patient’s symptoms again remitted.

Immunoglobulin G (IgG) and Cerebellar Ataxia Symptoms

Of interest, symptom severity corresponded to IgG levels. Her initial IgG levels were not reported, but after 19 treatments, when symptoms disappeared completely for the first time, her IgG levels were 354 mg/dL (day 134). When the symptoms appeared again (day 332) her IgG levels were elevated at 899 mg/dL. Upon treatment, her IgG levels dropped to 503 mg/dL as the nystagmus abated and then to 354 mg/dL upon complete remission, for the second time, at day 332 post HPV vaccine.

HPV16L and Post HPV Vaccine Reactions and Death

The researchers from this study, speculate a connection between the IgG response, and an as of yet, undetermined antibody. Testing for a variety of known antibodies were negative. Since the HPV16L is molecularly  similar to certain cell adhesion molecules, enzymes, transcription factors and neural antigens, it is possible that the HPV16L particles triggered the response.

In separate studies, autopsies of girls who died suddenly post HPV vaccine have found non-degrading HPV16L particles linked to the deaths. In the first case, researchers performed secondary postmortem immunochemistry of two girls who died suddenly after receiving Gardasil. They found evidence of cerebral vasculitis linked to the HPV16L particles throughout the cerebral vasculature.

Similarly, a postmortem exam of another girl who died from the HPV vaccine, found HPV16L DNA particles in the blood and spleen.  The researcher reported that the DNA fragments were found in the macrophages, and protected from degradation because of the tight binding of the HPV16L gene fragments to the aluminum adjuvant. The fragments underwent a conformational change rendering them more ‘stable’ and resistant to degredation, perhaps explaining their presence in the blood and spleen six months post vaccine. This has been contended.

Methods in both of the above studies have been controversial and questioned and should be interpreted with caution. However, researchers from Italy compared HPV16 proteome in the vaccine to the human to proteome and found 84 identical proteins involved in cell differentiation and neurosensory regulation. According to these researchers, the homology between the vaccine and the human proteome, bound to aluminum adjuvant

“make the occurrence of side autoimmune cross-reactions in the human host following HPV16-based vaccination almost unavoidable”.

Whatever the exact culprit, in this case the cerebellar ataxia was acute and temporally related to the HPV vaccine. The favorable response to immunoadsorption and consequent reduction in IgG levels, indicates an auto-immune response.

Mitochondrial Injury, Thyroid, Thiamine and Cerebellar Ataxia

With a more slowly developing cerebellar ataxia and related symptoms, it is possible a medication induced mitochondrial injury, related to a depletion of thiamine is present. Thiamine is critical for mitochondrial function. Similarly, patients have reported cerebellar ataxias related to Hashimoto’s. Generally, when testing for both thiamine deficiency and Hashimoto’s is undertaken, both are confirmed.

Final Thoughts

This report represents one of the first clear linkages between the HPV vaccine and acute cerebellar ataxia. More importantly, it suggests a treatment opportunity when caught early. With so little data available, it is not clear whether immunoadsorption would work for more chronic cases. However, there is evidence of its success in Guillian Barre, Myasthenia Gravis and other autoimmune conditions. When combined with the early data pointing to Hashimoto’s and thiamine deficiency, paths forward post injury are emerging.

Participate in Research

Hormones MatterTM is conducting research on the side effects and adverse events associated with Gardasil and its counterpart Cervarix. If you or your daughter has had either HPV vaccine, please take this important survey. The Gardasil Cervarix HPV Vaccine Survey.

We are also conducting research adverse reactions associated with the fluoroquinolone antibiotics, Cipro, Levaquin and Avelox: The Fluoroquinolone Antibiotics Side Effects Study.

To take one of our other surveys, click here.

To sign up for our newsletter and receive weekly updates on the latest research news, click here.

What Else Can I Do To Help?

Hormones MatterTM is completely unfunded at this juncture and we rely entirely on crowdsourcing and volunteers to conduct the research and produce quality health education materials for the public. If you’d like help us improve healthcare with better data, get involved. Become an advocate, spread the word about our site, our research and our mission. Suggest a study. Share a study. Join our team. Write for us. Partner with us. Help us grow. For more information contact us at: info@hormonesmatter.com.

To support Hormones Matter and our research projects – Crowdfund Us.

 

 

 

Related posts:

serotonin syndrome thiamineSerotonin Syndrome and Thiamine: Is There a Connection? thiamine dependencyThiamine Deficiency and Dependency Syndromes: Case Reports

You might be interested in

Marketing the HPV Vaccines to Prevent Cervical Cancer

Published on
3508 views
July Wilymen

HPV vaccines have been promoted to the public as a ‘vaccine to prevent cervical cancer’ (a non-infectious disease) yet these vaccines have never been demonstrated to prevent any cervical cancer. Six years after the HPV vaccine was implemented globally, Ian Frazer, the Australian inventor of the vaccine, stated ‘HPV vaccines may prevent cervical cancer.’ This is why the health department only refers to this vaccine as an ‘HPV vaccine’. In 2007 when the vaccine was approved for all women in many countries it was also known that there were 15 plus high-risk HPV strains that were associated with causing cervical cancer. Yet the HPV vaccine, Gardasil®, only covered 2 strains that were associated with cervical cancer – HPV 16 and 18 – the other 2 strains in the vaccine were associated with causing genital warts. This means there are 13 other high-risk HPV strains that are not covered in the Gardasil® vaccine and this is why vaccinated women will still require regular Pap screening.

Low Risk for Cancer

Women were also not informed that an infection with HPV is harmless and does not cause disease – cancer or warts – unless other co-factors are also present. These co-factors are not prevalent in developed countries. This is why Ian Frazer stated in 2005 ‘80-90% of cervical cancer occurs in the developing countries’. Not countries like Australia, Europe and the US. These countries have a low risk of cervical cancer. In Australia the death rate to cervical cancer when the vaccine was introduced in 2007 was 1.7 women /100,000. Pap screening combined with surgery is effective (9 out of 10 cancers) in detecting and preventing cervical cancer – and Pap screening will still be needed by vaccinated women. This means that it is not cost-effective for governments to be subsidizing the HPV vaccine when we already have an effective detection and prevention (surgery) in place that is virtually risk free.

HPV is Common

HPV is a common infection in all women. 80% of healthy women will have an HPV infection during their lifetime but this is harmless unless the co-factors are present that are necessary for the development of disease. In a developed country the risk of dying from cervical cancer is 0.25% but in developing countries it is 1.5%. Whilst the pharmaceutically funded marketing campaign informed women of the high incidence of HPV infection (80%) in women it did not inform women that the majority of these women are not at risk of developing cervical cancer or warts. The Australian Government states that the majority of women with an HPV infection are not at risk of cervical cancer.

This means that a drug has been recommended to all women but the majority of these women are not at risk of disease. However, many are now at risk from the side-effects of the vaccine. The government has not reduced the risk of disease with this policy but possibly increased the risk – at great expense. HPV vaccines are the most expensive vaccine on the market – $Au450 – yet the risks and benefits of this vaccine are still undetermined. The clinical trials had not been completed when the vaccine was approved for the market by the FDA in 2006. The safety of this vaccine has never been established.

The HPV vaccine had not been tested using an inert placebo in the unvaccinated group. The Merck funded clinical trial used aluminium adjuvant as the placebo in the unvaccinated group – this is a substance that is linked to causing autoimmune diseases and hypersensitivity. Comparing the vaccinated group to a group that is given aluminium adjuvant does not provide information on the harm this vaccine will cause in healthy people. The most frequent adverse reactions caused by this vaccine are neurological reactions such as seizures, convulsions, paralysis, tics, encephalopathy and thyroiditis. Many deaths have also been linked to the vaccine.

There were 21,265 adverse events reported to the US FDA and CDC alone up to September 2012. Many of these included permanent chronic illness and death. In 2013 the governments of India and Japan are no longer recommending this vaccine to the community.

This vaccine has only been trialled by the manufacturer of the vaccine, Merck, and it was promoted to the public by a campaign that was designed and funded by the manufacturer of the vaccine. In 2006 Merck won the ‘Brand of the Year’ for Gardasil® for creating a market out of thin air for this vaccine.

For the full report published in Infectious Agents and Cancer: HPV vaccination programs have not been shown to be cost-effective in countries with comprehensive Pap screening and surgery. Judy Wilyman’s research is being presented at the University of Wollongong, Faculty of Law, Humanities and the Arts, School of Social Sciences, Media and Communication.

Participate in Research

Hormones MatterTM is conducting research on the side effects and adverse events associated with Gardasil and its counterpart Cervarix. If you or your daughter has had either HPV vaccine, please take this important survey. The Gardasil Cervarix HPV Vaccine Survey.

To take one of our other Real Women. Real Data.TM surveys, click here.

To sign up for our newsletter and receive weekly updates on the latest research news, click here.

Related posts:

what the heck is oxalateWhat the Heck Are Oxalates and Why Should I Care? thiamine, hypoxia and bowel functionQuick Thoughts: Thiamine, Hypoxia, and Bowel Function Gastrointestinal tract and thiamineGastrointestinal Disease and Thiamine Secondary Hyperoxaluria -oxalate accumulationSecondary Hyperoxaluria: When Dietary Oxalate Accumulates

You might be interested in

Gardasil Cervarix Online Study Continues – Participate Now

Published on
3176 views
Gardasil Cervarix HPV Vaccine Survey

Controversy surrounds the HPV vaccines, Gardasil and Cervarix. Since their release, the vaccine industry, the media and medical societies have touted the safety and success of the vaccines in preventing or reducing HPV viral infections and thus, in preventing cervical cancer. Patient groups, mom’s of vaccine injured girls and anti-vaccine groups on the other hand, argue loudly that the rate and severity of serious adverse events are seriously under-reported by industry and the proof that these vaccines prevent or reduce cervical cancer is lacking. Even one of the lead developers of the vaccine, Diane Harper has come out against it.

Somewhere in the middle is the Vaccine Adverse Event Registry (VAERS), where only 1-10% of a very limited range adverse events are reported. Even with the limited reporting to VAERS, the severity and frequency of adverse events is growing and should not be ignored. Data collected from VAERS indicates a serious adverse event rate 4.3 per 100,000 doses of Gardasil. Serious adverse events are those that cause death or are life threatening, require hospitalization, cause persistent disability or incapacity and/or require medical treatment to prevent permanent impairment or damage. This is compared to a risk of cervical cancer of 7.9 per 100,000 and death from cervical cancer at 2.4 per 100,0000 cases in the US.

Considering the severity of the reported adverse reactions and the noted adverse events reporting rate of less than 10% of all cases, having more credible and complete data about true severity and prevalence of said reactions as well as more detailed data about who is at risk for those adverse events is critical.

As a parent, a researcher and the founder of Hormones MatterTM, I decided to do something about the lack of data in this and other areas of women’s health. As part of the Real Women, Real Data series,  The Gardasil Cervarix HPV Vaccine Survey was launched In May of 2013.  It is a comprehensive, online study of Gardasil and Cervarix side-effects and adverse events. The study will run until a study sample of 1000 is reached. The goal is to provide a more accurate and unbiased look at the rate, range and severity of side-effects and adverse events associated with the HPV vaccines, Gardasil and Cervarix.

Take a survey. Share a survey. Suggest a survey.

We need your help to gather these data.  Please take this survey, if have had either vaccine – whether you experienced any side-effects or not. Understanding who is at risk and who is not, is very important. Share the survey link with your friends, sisters, colleagues and anyone you know who has been given the HPV vaccine. Please post it on your Facebook pages and share on Twitter, Linkedin, Reddit and other social media. Write about and re-post this link on your blogs. Anything you can do to spread the word is appreciated. We will need at least a thousand women to find the connections.

It is up to us to protect our daughters. Understanding this vaccine is one way to do that.

Purpose the Gardasil – Cervarix Survey

Women and their physicians need more data about the side-effects of the HPV vaccines, Gardasil and Cervarix. There is a lack of data about who is at risk for adverse events and whether certain pre-existing conditions increase one’s risk for an adverse event. There is also a lack of data about the long term health effects of these vaccines. The purpose of this survey is to fill that data void; to learn more about the risks for and nature of adverse events associated with each of the HPV vaccines, Gardasil and Cervarix.

Who Should Take the Gardasil Cervarix HPV Vaccine Survey?

Girls or women who have been given either vaccine or the parents or other family members of young girls given the vaccine.

We are not currently collecting data on the adverse reactions for men and boys, but intend to launch a separate survey to tackle that population.

How Long Does the Gardasil Cervarix HPV Vaccine Survey Take?

This is a long survey. We felt it was important to assess the full depth, breadth, onset and severity of adverse reactions in order to give parents and women the data they need to make informed medical decisions. This necessitated a longer than desired survey. We estimate it will take approximately 20-30 minutes to complete the survey.  We hope, given what is at risk, survey respondents will take the time to complete the entire survey.

Is the Survey Anonymous and Secure?

Yes. We do not collect personal identifying information and the survey is hosted with SSL encryption using a verisign certificate Version 3, 128 bit encryption.

How Will the Data be Used?

To inform future research and women’s health decision-making.

Who is Conducting this Research?

Researchers from LucineTM, Hormones MatterTM. For more information on Lucine, click here. For more information about Hormones MatterTM , click here.

What Can I Do To Help?

Our organization is completely unfunded at this juncture and we rely entirely on crowdsourcing and volunteers to conduct the research and produce quality health education materials for the public. Get involved and help us prove that hormones matter and that women’s health data matter. Become an advocate, spread the word about our site, our research and our mission. Join our team. Write for us, partner with us, help us grow. For more information contact us at: info@hormonesmatter.com.

To take the Gardasil Cervarix HPV Vaccine Survey, click here.

To take one of our other Real Women. Real Data.TM surveys, click here.

To sign up for our newsletter and receive weekly updates on the latest research news, click here.

Thank you in advance for your help.

Related posts:

No related posts.

You might be interested in

Wal-Mart to Offer HPV Vaccine

Published on
2327 views

Now, in addition to low priced groceries and other goods, your local Wal-Mart will offer nurse kiosks ready to inject you or your child with a variety of vaccines. Wal-Mart is joining other stores, like Walgreens and CVS, in offering walk-through health clinics. According to recent reports, Wal-Mart will be the first to offer the controversial HPV vaccines Gardasil and Cervarix.

At Hormones MatterTM, we have written a lot about Gardasil and the HPV vaccine questioning its safety. Gardasil: Miracle or Deadly Vaccine?, Is Gardasil Mandated in Your State?, What About the Pap Smear?. For a very heartbreaking story at the dangerous side effects of this story please read A Ruined Life from Gardasil. HPV is a very common virus that many experts believe the body can fight off by itself; with annual pap smear tests a doctor can easily catch and remove any abnormal cells before they become cancer.

The trend of selling direct-to-consumer vaccines, like that of selling over-the-counter medications is time-saving and logical on the one hand, but is troubling on the other, especially with vaccines and medications that have less than stellar safety profiles. Any product sold direct-to-consumer comes with the false presumption that it is entirely safe. Indeed, we have consumer protection agencies to ensure that this is the case with most products. Consumers often mistakenly assume that over-the-counter medications are safe because there is a consumer protection agency protecting their well-being, otherwise the product would not be on the market. Unlike a toy with a choking hazard or a product batch with a chemical contaminant, where the cause and effect are obvious and easily remedied with recall, the direct side-effects or adverse reactions of medications or vaccines are difficult to recognize and more difficult to prove, even under the most regulated of circumstances. When medications or vaccines are sold over-the-counter, it is nearly impossible.

The over-the-counter vaccines effectively remove any ability for physicians, researchers or patients identify side-effects. Selling over-the-counter vaccines is a boon to the pharmaceutical industry, however. With this single move the industry can sell more vaccines, the vaccines become safe in the eyes of the consumer while the industry removes the ability to prove otherwise, and a brilliant, albeit less than ethical, corporate strategy is pushed on consumers.

What do you think, should vaccines be available at the local pharmacy?

Hormones MatterTM is conducting research on the side effects and adverse events associated with Gardasil and its counterpart Cervarix. If you or your daughter has had either HPV vaccine, please take this important survey. The Gardasil Cervarix HPV Vaccine Survey. 

Related posts:

Bladder pain - Interstitial cystitisBladder Pain Syndrome – Interstitial Cystitis hypoxic oceans hypoxic humansThe Oceans Are Hypoxic and So Are We frack waterWater Contamination Near Fracking Sites: Dangerous Endocrine Disruptors What would Rachel Carson DoGardasil and the American Bald Eagle – What Would Rachel Carson Do?

You might be interested in

Gardasil: Miracle or Deadly Vaccine?

Published on
8711 views

I normally don’t speak for a larger population because we are all unique individuals; however, I think in this case I can speak for all women. Dread is the only emotion that is drudged up when you get the friendly reminder card in the mail that it’s time for your annual appointment. Stripping down and wearing a stiff hospital gown with your feet up in cold metal stirrups while a doctor sticks a cold, duck-lip looking contraption up your nether regions for a Papanicolaou (pap) test. I don’t think there is a single woman on earth who enjoys this necessary torture, but it is the primary way to detect diseases and/or conditions including cervical cancer.

That is until 2008, when Merck released a vaccine that is advertised to protect against the strands of the Human Papillomavirus (HPV) that cause cervical cancer and genital warts. The shot is being administered to young girls and boys (who can carry the disease, but do not suffer from any health conditions because of it). The shot is administered to girls ages 11-26 years-old and boys age 9-26 years old, but do the pros outweigh the cons? I’ve heard of doctors tell parents, I wouldn’t give this shot to my own child, how can I recommend it to my patients. And I’ve heard doctors say, it’s the greatest vaccine we have that actually protects against cancer.

Let’s look at whether or not prevention outweighs the serious side effects and risks.

HPV

Carolyn Vachani, RN, MSN, AOCN writes that, “The Human Papilloma Virus (HPV) is one of the most common sexually transmitted infections (STI) in the world. It is estimated that 5.5 million people worldwide are infected annually. Sexually active individuals have an 80 to 85% chance of being infected at some time in their life.” It’s not just a sexually transmitted infection; the virus invades the epithelial cells (type of skin cell) on other parts of the body including the oral mucosa, esophagus, larynx, trachea, and conjunctiva of the eye. Further more Vachani writes, “Researchers have identified 100 different strains of HPV, 40 of which can infect the anal and genital areas.”

On Merck’s Gardasil website it boasts, “GARDASIL is the only human papillomavirus (HPV) vaccine that helps protect against 4 types of HPV.” So, what about the other 96 strands, 36 of which infect the anal and genital areas?

Like HIV, there is no cure for HPV; but unlike HIV, the body can fight HPV and win 80% of the time. For the 20% whose body cannot fight off HPV there is a risk that cervical cancer can develop. If it is a strand that causes genital warts there are various methods to treat and get rid of the warts until the body is able to fight off the infection on its own.

Cervical Cancer

In spite of the high odds the body can fight off an HPV infection, cervical cancer is the second most common cancer in women worldwide. Forty years ago, cervical cancer was the leading cause of death of women in the US, but thanks to the availability of the pap test that has decreased 75% over the past 50 years. With annual pap tests, precancerous cells can be detected and removed from the cervix rather simply. According to the CDC, in 2008:

  • 12,410      women in the United States were diagnosed with cervical cancer.
  • 4,008      women in the United States died from cervical cancer.

Those numbers are low compared to developing countries. Out of the approximately 500,000 new cases of cervical cancer annually, 83% are in developing countries. The annual death rate of cervical cancer worldwide is approximately 273,000, of which developing countries account for 75% of the deaths.

There are no symptoms of cervical cancer and no way to detect it except a pap test, which isn’t available in most developing countries explaining the higher mortality rates. A vaccine that protects against the most common strands of the virus is better than nothing, right? Well, let’s take a closer look and see what the controversy is all about.

Gardasil

FDA approved Gardasil on June 8, 2006. As Chandler Marrs reported in Why Few Women Trust the FDA, the FDA doesn’t always have the best record in women’s health, making it difficult to believe everything they pass is safe or effective. The vaccine is a series of three shots taken over the course of a year. On the FDA website it states, “Given the large number of doses distributed, it is expected that, by chance alone, serious adverse events and some deaths will be reported in this large population during the time period following vaccinations.”

How many deaths and serious side effects are acceptable for the FDA? Apparently quite few; Natural Society reports, “Between May 2009 and September 2010 alone, Gardasil was linked to 3,589 harmful reactions and 16 deaths. Of the 3,589 adverse reactions, many were debilitating. Permanent disability was the result of 213 cases; 25 resulted in the diagnosis of Guillain-Barre Syndrome; and there were 789 other “serious” reports according to FDA documents.”

What does the FDA have to say? “Concerns have been raised about reports of deaths occurring in individuals after receiving Gardasil. As of December 31, 2008, 32 deaths had been reported to VAERS [Vaccine Adverse Event Reporting System]. There was not a common pattern to the deaths that would suggest they were caused by the vaccine.”

On the website Classaction.org, where you can get legal advice on class action law suits against the makers of Gardasil if you or your child has suffered from side effects, they state, “As of Feb. 14, 2011, the CDC has reported that there have been 51 reports of deaths among females who received the HPV vaccine. A total of 32 of these death reports have been confirmed, meaning that a doctor has reviewed the report and any associated records. There have been two reports of deaths among males who were injected with Gardasil.”

That is just in America where cervical cancer can be detected early with annual pap tests. The vaccine against HPV is given worldwide to girls and boys to prevent spreading of HPV. It is now marketed as prevention against anal cancer even though only 10% of women with HPV will develop cancer and  cancer associated with HPV is only responsible for 1% of all cancer deaths.

Judicial Watch

In 2011, Judicial Watch, a conservative, non-partisan educational foundation that promotes transparency, accountability and integrity in government, politics and the law stepped in. They reported that they, “received new documents from the U.S. Food and Drug Administration (FDA) under the provisions of the Freedom of Information Act (FOIA), detailing reports of adverse reactions to the vaccination for human papillomavirus (HPV), Gardasil. The adverse reaction reports detail 26 new deaths reported between September 1, 2010 and September 15, 2011 as well as incidents of seizures, paralysis, blindness, pancreatitis, speech problems, short term memory loss and Guillain-Barré Syndrome. The documents come from the FDA’s Vaccine Adverse Event Reporting System (VAERS).”

The report also states, “Not only will Gardasil not cure pre-existing HPV, it can also make symptoms worse. Women who already have the virus without knowing it could suffer massive outbreaks of genital warts or abnormal precancerous lesions, both of which require extensive treatment.” The vaccine is suggested for women who test positive for HPV in order to prevent them from contracting the other strands. (The 25 page report can be viewed here.)

Conclusion

Merck’s website advertises “You/your son or daughter could be one less person affected by HPV disease.” It is important to research all the possible side effects and the rate of occurrence, as well as your/your daughter’s ability to have annual pap tests before making this decision. We are all exposed to numerous strands of the HPV virus. Of the 100 strands, 40 are contacted through sex or genital skin contact. Of those 40, Gardasil only protects against the 4 most common strands because adding more strands to the vaccine caused even more severe side effects. In 80% of the cases of genital HPV, the body fights off the infection. With pap tests, doctors can detect cervical cancer before it becomes deadly (as long as women are getting them done annually). As much as we all hate that annual appointment, it may be a better solution to stick our legs in the stirrups for an exam rather than risk the side effects of the Gardasil vaccine. You decide.

Next week, I will look at how Gardasil was approved by the FDA, how states are mandating it for school children, and how states are passing legislation to make it legal for health professionals to administer the shot to minors without parental consent.

Additional Resources

IARC Monographs on Human Papillomavirus Virus and Studies of Cancer in Humans

Is Gardasil mandated in your state? Read more here
How does a Pap Smear Test prevent cervical cancer? Read more here.

Participate in Research

Hormones MatterTM is conducting research on the side effects and adverse events associated with Gardasil and its counterpart Cervarix. If you or your daughter has had either HPV vaccine, please take this important survey. The Gardasil Cervarix HPV Vaccine Survey. 

Related posts:

Lupron oophorectomy mitochondriaA Rant about Lupron and Oophorectomy, Some Mechanisms and Clues to Recovery breathing easy with thiamineBreathing Easy With Thiamine Pyrophosphate adverse drug reactionsAdverse Drug Reactions (ADRs): We’re ALL at Risk iatrogenic illnessIatrogenic Illness and Pharmaceutical Side Effects

You might be interested in